Esophageal candidiasis: Difference between revisions
ClaireLewis (talk | contribs) No edit summary |
Ostermayer (talk | contribs) |
||
| Line 26: | Line 26: | ||
==Disposition== | ==Disposition== | ||
*Depends on ability to tolerate oral solids and liquids. Most patients will be dispositioned home with outpatient followup. | |||
==See Also== | ==See Also== | ||
Revision as of 12:42, 20 October 2022
Background
- Most commonly seen in HIV patients with CD4 count < 100 (AIDS-defining illness) or chronic inhaled glucocorticoid use
Clinical Features[1]
- Odynophagia
- Dysphagia
- Retrosternal pain
- Nausea/vomiting
Differential Diagnosis
Esophagitis
- Esophageal candidiasis
- CMV esophagitis
- HSV esophagitis
- Eosinophilic esophagitis
- Medication-induced esophagitis
Evaluation
- Thick, white, linear esophageal plaques on endoscopy
Management
- Fluconazole 400mg PO loading dose, followed by 200mg PO Qdaily x 2 weeks
- Itraconazole 200mg PO Qdaily for 2 weeks
- has more nausea side-effects and drug interactions compared to fluconazole
Disposition
- Depends on ability to tolerate oral solids and liquids. Most patients will be dispositioned home with outpatient followup.
See Also
External Links
References
- ↑ Kauffmann CA. Overview of Candida Infections. UptoDate. 2016.